Ruben Smith
81 – 90 of 104
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Comparing 18 F-AV-1451 with CSF t-tau and p-tau for diagnosis of Alzheimer disease
- Contribution to journal › Article
- 2017
-
Mark
Tau neuropathology correlates with FDG-PET, but not AV-1451-PET, in progressive supranuclear palsy
- Contribution to journal › Article
-
Mark
Increased basal ganglia binding of 18F-AV-1451 in patients with progressive supranuclear palsy
- Contribution to journal › Article
-
Mark
Distinct 18F-AV-1451 tau PET retention patterns in early- and late-onset Alzheimer's disease
- Contribution to journal › Article
-
Mark
Modeling strategies for quantification of in vivo 18F-AV1451 binding in patients with tau pathology
- Contribution to journal › Article
-
Mark
Tau pathology distribution in Alzheimer's disease corresponds differentially to cognition-relevant functional brain networks
- Contribution to journal › Article
-
Mark
18F-AV-1451 and CSF T-tau and P-tau as biomarkers in Alzheimer's disease
- Contribution to journal › Article
-
Mark
In vivo retention of (18)F-AV-1451 in corticobasal syndrome
- Contribution to journal › Article
- 2016
-
Mark
18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers
- Contribution to journal › Article
-
Mark
Posterior accumulation of tau and concordant hypometabolism in an early-onset Alzheimer's disease patient with presenilin-1 mutation
- Contribution to journal › Article
